Quotes 5-day view Delayed Nasdaq
05/24/2023
05/25/2023
05/26/2023
05/30/2023
05/31/2023
Date
5.14(c)
5.24(c)
5.51(c)
5.53(c)
5.43 Last
782 926
1 229 753
1 259 463
907 519
1 071 765 Volume
-1.53% +1.95% +5.15% +0.36% -1.81% Change
Estimated financial data (e) (USD)
Sales 2023
762 M - -
Net income 2023
-17,1 M - -
Net cash position 2023
66,4 M - -
P/E ratio 2023
-124x
Yield 2023
-
Sales 2024
851 M - -
Net income 2024
21,3 M - -
Net cash position 2024
196 M - -
P/E ratio 2024
112x
Yield 2024
-
Capitalization
2 155 M 2 155 M -
EV / Sales 2023
2,74x
EV / Sales 2024
2,30x
Nbr of Employees
953
Free-Float
10,6%
GoodRx Holdings, Inc. is a consumer-focused digital healthcare platform in the United States. The Company offers consumers free access to the prices for branded and generic medications, medical provider consultations via telehealth, and comprehensive healthcare research and information. The Company aggregates prescription pricing data points from sources spanning the healthcare industry. It structures and normalizes...
Ratings of GoodRx Holdings, Inc.
All news about GOODRX HOLDINGS, INC.
05/25 GoodRx to Present at the Jefferies Healthcare Conference BU
05/23 FTC Takes Action Against Health App For Alleged Privacy Violations AQ
05/12 Goldman Sachs Trims Price Target on GoodRx Holdings to $6.25 From $7, Maintains Neutral.. MT
05/11 Transcript : GoodRx Holdings, Inc. Presents at Bank of America Securities 202.. CI
05/11 BofA Securities Adjusts GoodRx Holdings' Price Target to $8 From $9, Keeps Buy Rating MT
05/11 Deutsche Bank Adjusts GoodRx Price Target to $6 From $8, Maintains Hold Rating MT
05/11 UBS Adjusts GoodRx Price Target to $5.50 From $6, Maintains Neutral Rating MT
05/11 Citigroup Adjusts Price Target on GoodRx Holdings to $7 From $7.50, Keeps Buy Rating MT
05/10 Tranche Update on GoodRx Holdings, Inc.'s Equity Buyback Plan announced on February 28,.. CI
05/10 Transcript : GoodRx Holdings, Inc., Q1 2023 Earnings Call, May 10, 2023 CI
05/10 GoodRx Holdings' Q1 Adjusted Earnings, Revenue Drop; Sets Q2, Lowers 2023 Revenue Guida.. MT
05/10 North American Morning Briefing: Caution -2- DJ
05/10 Goodrx Holdings, Inc. : Results of Operations and Financial Condition, Financial Statement.. AQ
05/10 Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q1 EPS $0.07, vs. Street Est of $0.06 MT
05/10 Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q1 Revenue $184M, vs. Street Est of $182... MT
News in other languages on GOODRX HOLDINGS, INC.
Analyst Recommendations on GOODRX HOLDINGS, INC.
ETFs positioned on GOODRX HOLDINGS, INC. ETFs and Trackers with Trackinsight
Chart GOODRX HOLDINGS, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends GOODRX HOLDINGS, INC.
Short Term Mid-Term Long Term Trends Neutral Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
5,43 $
Average target price
6,41 $
Spread / Average Target
18,0%
Please enable JavaScript in your browser's settings to use dynamic charts.
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Weight
